| 1 |
Vector Saliva in Vaccines for Visceral Leishmaniasis: A Brief Encounter of High Consequence? |
|
|
| Shaden Kamhawi,Hamide Aslan,Jesus G. Valenzuela |
|
| Frontiers in Public Health. 2014; 2 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Stability and toxicity of heteroleptic organometallic Bi(v) complexes towards Leishmania major |
|
|
| Yih Ching Ong,Victoria L. Blair,Lukasz Kedzierski,Philip C. Andrews |
|
| Dalton Transactions. 2014; 43(34): 12904 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Oral azithromycin versus its combination with miltefosine for the treatment of experimental Old World cutaneous leishmaniasis |
|
|
| Eglal I. Amer,Maha M. Eissa,Shereen F. Mossallam |
|
| Journal of Parasitic Diseases. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Poly(methacrylic acid) complexation of amphotericin B to treat neglected diseases |
|
|
| Karolina Alicja Les,Abeer H. A. Mohamed-Ahmed,Sibu Balan,Ji-won Choi,Denis Martin,Vanessa Yardley,Keith Powell,Antony Godwin,Steve Brocchini |
|
| Polymer Chemistry. 2014; 5(3): 1037 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Drug repurposing and human parasitic protozoan diseases |
|
|
| Katherine T. Andrews,Gillian Fisher,Tina S. Skinner-Adams |
|
| International Journal for Parasitology: Drugs and Drug Resistance. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Análisis de la utilización de anfotericina B liposomal |
|
|
| María González Martínez,Carolina Mariño Martínez,Gema Baldominos Utrilla,María Nélida Fernández Martínez |
|
| Revista Iberoamericana de Micología. 2013; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Noncovalent Complexation of Amphotericin-B with Poly(a-glutamic acid) |
|
|
| Abeer H. A. Mohamed-Ahmed,Karolina A. Les,Karin Seifert,Simon L. Croft,Stephen Brocchini |
|
| Molecular Pharmaceutics. 2013; 10(3): 940 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Modes of action of Leishmanicidal antimicrobial peptides |
|
|
| Alexandra K Marr,Bradford S McGwire,W Robert McMaster |
|
| Future Microbiology. 2012; 7(9): 1047 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
A pilot study comparing low-dose liposomal amphotericin B with N-methyl glucamine for the treatment of American cutaneous leishmaniasis |
|
|
| J.O.C. Motta,R.N.R. Sampaio |
|
| Journal of the European Academy of Dermatology and Venereology. 2012; 26(3): 331 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
A novel mechanism for an old drug: Amphotericin B in the treatment of visceral leishmaniasis |
|
|
| Amitabha Chattopadhyay,Md. Jafurulla |
|
| Biochemical and Biophysical Research Communications. 2011; 416(1-2): 7 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Rare splenic complications and specific serology: decisive diagnostic tools in two cases of visceral leishmaniasis |
|
|
| Andrea Celestini,Federica Paglia,Orlando Dell’ Unto,Riccardo Guarisco,Claudio Puoti |
|
| Italian Journal of Medicine. 2011; 5(4): 274 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Amphotericin B Membrane Action: Role for Two Types of Ion Channels in Eliciting Cell Survival and Lethal Effects |
|
|
| B. Eleazar Cohen |
|
| The Journal of Membrane Biology. 2010; 238(1-3): 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
